LSPedia Receives Inc. 5000 Ranking Honor
In the midst of providing DSCSA support, the SaaS provider is awarded for being a fast-growing, private US company.
LSPedia, a software-as-a-service (SaaS) provider that specializes in product traceability solutions for the pharma industry, has been named to Inc’s 2023 Inc. 5000 list of the fastest-growing private companies across the US. Founded in 2013 by CEO Riya Cao, LSPedia aims to assist dispensers, healthcare providers (HCPs), wholesale distributors, manufacturers, contract manufacturing organizations (CMOs), and third-party logistics providers (3PLs) with navigating the Drug Supply Chain Security Act (DSCSA).
With full regulatory enforcement of DSCSA set to take effect on Nov. 27, LSPedia's OneScan solution has become a product whose goal is to provide affordable compliance. Specifically, OneScan enables DSCSA functions such as EPCIS data exchange, trading partner onboarding, and product reconciliation with data.
"This recognition validates years of planning and effort, and underscores our mission to enhance FDA DSCSA compliance,” comments Cao. “We're honored to have earned trust throughout the pharmaceutical industry, and we'll continue to build through innovation, expertise, and dedication to customer success."
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
